In agreement with in vitro findings, this study demonstrated that genetic or pharmacological blockade of TRPA1 retarded breast and lung cancer growth and suppressed chemoresistance in immunocompromised mice and confirmed that tumor cells were also exposed to higher oxidative stress in vivo. This evidence concerns the gene TRPA1 and lung cancer.